Blue Cross NC prior authorization criteria
Submission criteria, documentation packets, and P2P prep by drug — for prescribers and PA staff. 30-day standard PA decision.
Blue Cross NC reviews prior-authorization requests against its published medical policies — diagnosis with ICD-10 code, documented step-therapy history, and prescriber attestation of medical necessity. Standard PA decisions return in 30 days; if denied, prescribers and members have 180 days to appeal. Criteria by drug below.
Prior authorization criteria by drug
Each page covers Blue Cross NC's submission criteria, the documentation packet, and peer-to-peer prep for that drug.
- Adalimumab at Blue Cross NC →
- Aflibercept at Blue Cross NC →
- Apixaban at Blue Cross NC →
- Atezolizumab at Blue Cross NC →
- Atogepant at Blue Cross NC →
- Benralizumab at Blue Cross NC →
- Bevacizumab at Blue Cross NC →
- Bictegravir at Blue Cross NC →
- Buprenorphine at Blue Cross NC →
- Dapagliflozin at Blue Cross NC →
- Dulaglutide at Blue Cross NC →
- Dupilumab at Blue Cross NC →
- Eculizumab at Blue Cross NC →
- Elexacaftor Tezacaftor Ivacaftor at Blue Cross NC →
- Empagliflozin at Blue Cross NC →
- Erenumab at Blue Cross NC →
- Evolocumab at Blue Cross NC →
- Faricimab at Blue Cross NC →
- Fingolimod at Blue Cross NC →
- Fremanezumab at Blue Cross NC →
- Galcanezumab at Blue Cross NC →
- Glecaprevir Pibrentasvir at Blue Cross NC →
- Guselkumab at Blue Cross NC →
- Ibrutinib at Blue Cross NC →
- Imatinib at Blue Cross NC →
- Inclisiran at Blue Cross NC →
- Infliximab at Blue Cross NC →
- Ixekizumab at Blue Cross NC →
- Lenalidomide at Blue Cross NC →
- Liraglutide at Blue Cross NC →
- Lisdexamfetamine at Blue Cross NC →
- Mepolizumab at Blue Cross NC →
- Methylphenidate at Blue Cross NC →
- Naltrexone at Blue Cross NC →
- Natalizumab at Blue Cross NC →
- Nintedanib at Blue Cross NC →
- Nivolumab at Blue Cross NC →
- Nusinersen at Blue Cross NC →
- Ocrelizumab at Blue Cross NC →
- Ofatumumab at Blue Cross NC →
- Omalizumab at Blue Cross NC →
- Ozanimod at Blue Cross NC →
- Palbociclib at Blue Cross NC →
- Pembrolizumab at Blue Cross NC →
- Pirfenidone at Blue Cross NC →
- Ribociclib at Blue Cross NC →
- Rimegepant at Blue Cross NC →
- Risankizumab at Blue Cross NC →
- Rituximab at Blue Cross NC →
- Rivaroxaban at Blue Cross NC →
- Sacubitril Valsartan at Blue Cross NC →
- Secukinumab at Blue Cross NC →
- Semaglutide at Blue Cross NC →
- Sofosbuvir at Blue Cross NC →
- Tafamidis at Blue Cross NC →
- Tenofovir Alafenamide at Blue Cross NC →
- Tezepelumab at Blue Cross NC →
- Tirzepatide at Blue Cross NC →
- Tofacitinib at Blue Cross NC →
- Trastuzumab at Blue Cross NC →
- Upadacitinib at Blue Cross NC →
- Ustekinumab at Blue Cross NC →
Generate a Blue Cross NC PA packet
Open ApprovalHelp — generate a prior-auth packet tailored to Blue Cross NC's criteria, with prescriber attestation and step-therapy documentation pre-filled.
Get started →Contact: hello@approvalhelp.com